Potential Claim Construction Error Is Harmless When Not Relied Upon by the Board
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Ashley C. Morales & Hans L. Mayer
BOT M8 LLC v. SONY INTERACTIVE ENTERTAINMENT LLC
Before Prost, Reyna, and Cunningham. Appeal from the Patent Trial and Appeal Board.
Summary: A party challenging the Board’s decision by alleging claim construction errors must demonstrate the harmfulness of the alleged errors for the Board’s decision to be reversed.
Sony petitioned for IPR of Bot M8’s patent directed to a gaming machine that authenticates certain data. The Board determined that the independent claims of the patent were unpatentable as obvious over several references. The Board’s decision relied, in part, on a claim construction that permitted writing some data to the motherboard before authenticating the game program, as long as the entire game program was not written to the motherboard before authenticating the game program.
The Federal Circuit affirmed the Board’s decision. The Court rejected Bot M8’s assertion that the independent claims precluded writing any data, game program or not, to the motherboard before authenticating the game program. The Federal Circuit then considered whether the claims precluded writing any portion of the game program to the motherboard before authenticating the game program. The Federal Circuit held that, even if Bot M8’s proposed construction was correct, the Board’s decision should still be affirmed because Bot M8 failed to demonstrate that the Board actually relied on a construction that permitted writing portions of the game program to the motherboard before authenticating the game program. The Federal Circuit concluded that the Board would not have needed to rely on the alleged incorrect construction because the invalidating prior art references each only wrote non-game programing data to the motherboard before authenticating the game program.
Editor: Paul Stewart
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…